Document is current
Any future updates will be listed below
-
Authors
Sinapidis, Dimitrios
Kosmas, Vassileios
Vittoros, Vasileios
Koutelidakis, Ioannis M.
Pantazi, Aikaterini
Stefos, Aggelos
Katsaros, Konstantinos E.
Akinosoglou, Karolina
Bristianou, Magdalini
Toutouzas, Konstantinos
Chrisofos, Michael
Giamarellos-Bourboulis, Evangelos J. https://orcid.org/0000-0003-4713-3911
-
Funding
Funding for this research was provided by:
Hellenic Institute for the Study of Sepsis
- License Information
-
More Information
Article History
Received: 27 June 2017
Accepted: 21 May 2018
First Online: 29 May 2018
Ethics approval and consent to participate
: The protocol was approved by the following Ethics Committees:Written informed consent was provided by the patients or by a legal representative in case of patients unable to consent.
: EJ Giamarellos-Bourboulis has received honoraria (paid to the University of Athens) from AbbVie, Biotest, Brahms GmbH, and The Medicines Company; he has received compensation as a consultant for Astellas Greece (paid to the University of Athens); and has received independent educational grants (paid to the University of Athens) from AbbVie, Biotest, and Sanofi. He is funded by the FrameWork 7 program HemoSpec and by the Horizon 2020 program European Sepsis Academy (granted to the University of Athens). None of the other authors has any other type of financial conflict to disclose.The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
